https://www.degruyter.com/cookie/doi/10.1515/mr-2023-0031/html [3]Muth J,et al.WU-NK-101, an enhanced memory natural killer (NK) cell therapy, with cetuximab (Ctx) for the treatment of advanced colorectal cancer (CRC)[J]. 2023.https://ascopubs.org/doi/abs/10.1200/JCO.2023.41....
2. Geller, Melissa A et al. “A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.” Cytotherapy vol. 13,1 (2011): 98-107.3. Yang, Yaewon et al. “Phase I Study of Random Healthy Donor-Derived Allogeneic Natural ...
1.Shindo G, Endo T, Miyamoto Y, et al. Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer: A Case Report. British Journal of Cancer Research. 2021; 4:2. 2.Investigation of the efficacy and feasibility o...
“A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.” Cytotherapy vol. 13,1 (2011): 98-107. 3. Yang, Yaewon et al. “Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with ...
Judson, R. Ghebre, L.F. Carson, P.A.Argenta, A.L. Jonson, A. Panoskaltsis-Mortari, J. Curtsinger, D. McKenna, K.Dusenbery, R. Bliss, L.S. Downs, J.S. Miller A phase II study of allogeneicnatural killer cell therapy to treat patients with recurrent ovarian and breastcancer Cyto...
2. Geller, Melissa A et al. “A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.” Cytotherapy vol. 13,1 (2011): 98-107. 3. Yang, Yaewon et al. “Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer...
2024年9月9日,《scientific reports》报告了同种异体自然杀伤细胞(NK)疗法在自体造血干细胞移植后复发/难治性神经母细胞瘤患者中的I期研究疗效,题为“Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell tr...
2024年9月9日,《scientific reports》报告了同种异体自然杀伤细胞(NK)疗法在自体造血干细胞移植后复发/难治性神经母细胞瘤患者中的I期研究疗效,题为“Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell tr...
NK细胞是免疫系统中最有效的自然杀伤细胞(natural killer cell,NK),不仅与抗肿瘤、抗病毒感染和免疫调节有关,在某些情况下,它还参与超敏反应和自身免疫性疾病的发生,能够识别靶细胞、杀伤介质。 NK细胞属于粒状淋巴细胞,是人体免疫系统的组成部分。它能迅速溶解某些肿瘤细胞,因此开发它的抗癌功能是近年来癌症研究的重...
Long-term, 25-year Survival Following Surgery and Immune Cell Therapy Combined with Chemotherapy for HER2-Positive Metastatic Breast Cancer: A Case Report. British Journal of Cancer Research. 2021; 4:2. 2.Investigation of the efficacy and feasibility of combined therapy of PD‐L1‐enhanced ...